Newsletter | March 24, 2020

03.24.20 -- AMSBIO Launch Coronavirus - COVID-19 Research Products

Featured Editorial
A Technology Roadmap For Today’s Gene Therapy Manufacturing Challenges
By Ruben Carbonell, Arpan Mukherjee, Jonathan Dordick, and Christopher J. Roberts

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published technology roadmaps addressing needs and gaps in three key product areas: gene therapy, antibody-dug conjugates, and vaccines. The roadmaps were developed with the collaborative input of industry, academic, and government experts. This article highlights technology opportunities for gene therapy manufacturing.

Beyond Human Error: Are Blunt- Or Sharp-End Decisions More Important In The Life Sciences?
By Jim Morris, NSF Health Sciences Pharma Biotech

Decisions made upstream in the supply chain can have enormous repercussions downstream at the bedside or in the home, where medications are administered. How do we guarantee that the big and seemingly small decisions being made with each batch manufactured will be the “right” ones when there is so much inherent variability around us?

Cats In The Warehouse! 9 Real-Life Blunders To Avoid In Your Pharma Facility
By Herman F. Bozenhardt and Erich H. Bozenhardt

Our previous review of humorous and horrifying pharmaceutical facilities blunders Pigeons In The Plant: 10 Real-Life Pharma Facility Blunders (And How To Avoid Them) revealed our industry is flawed like any other. Here are some examples from the engineering side of the business.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.